New Jersey, USA-based leading global network of physician-only platforms for programmatic messaging, Doceree raised USD 35 million in Series B. The company announced the fundraise on September 27, 2023. Creaegis, the leading digital and technology investment firm, led the financing for the company. Meanwhile, existing investors such as Eight Roads Ventures and F-Prime Capital also participated in the round.
Purpose of financing for Doceree
With the latest proceeds, Doceree seeks to accelerate product development. It also seeks to augment technologies. In addition, the company has plans to scale global expansion. Besides, the company has plans to ramp up its hiring operations and expand its team.
What the company’s official has to add
Harshit Jain, MD, Founder and global CEO of the company, said, “We are pioneering HCP messaging solutions that are first to market. It is incredible to watch our innovative products disrupt the space and drive the adoption of programmatic technology in the life-sciences industry, not just in evolved markets like the US but also elsewhere in the same vein. We have been able to simplify HCP engagement globally with our unique AI-enabled proprietary technology and offer quality end-to-end HCP-targeting solutions that have helped our clients succeed with profitable growth. The pharma messaging space is evolving at a fast pace, and our solutions are aligned to meet the immediate requirements of the life sciences industry. The investment speaks volumes about the value we are creating in the space. We are growing massively and have a competitive edge. We are thrilled about the future as we continue to expand and touch new horizons in the space.”
What the investors have to comment
Prakash Parthasarathy, Managing Partner & CIO and Nitish Bandi, Partner, Creaegis, further said, “We are excited to partner with Harshit and the Doceree team to support the company in its next phase of growth led by an industry-leading digital platform driven by deep learning-based data models. Our past experience of investing in pioneering global SaaS companies and in the healthcare ecosystem will enable us to support the company’s mission to create superior outcomes for pharma brands, providers and patients.”
In addition, Ashish Venkataramani, Partner, Eight Roads Ventures, said, “Doceree’s technology platform allows biopharmaceutical companies to connect with physicians like never before. The company’s impressive growth trajectory is an outcome of its unique, data-driven approach to enabling communication with precision and relevance. It has been exciting to partner with Harshit and the team since their Series A round, and we are thrilled to continue supporting their pioneering work.”
About the company
Daleep Manhas, Harshit Jain, Michael Fishweicher, and Stephen Hoelper launched the company in 2019. Doceree empowers not just pharmaceutical and life-sciences companies but also healthcare media agencies. It provides them with solutions, seamlessly reaching HCPs on their networks and within their digital workflows to achieve better patient health outcomes.
For more extensive analysis and Market Intelligence reports, feel free to approach us.
We try our best to fact-check and bring well-researched as well as non-plagiarized content to you. Please let us know
if there are any discrepancies in any of our published stories,
-how we can improve,
-what stories you would like us to cover
–what information you are looking for in the comments section below or through our contact form! We look forward to your feedback, and thank you for stopping by!
Next Article
